71 – 80 of 87
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2001
-
Mark
Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues
- Contribution to journal › Article
- 2000
-
Mark
Time-resolved fluorometry in end-point and real-time PCR quantification of nucleic acids
- Contribution to journal › Article
-
Mark
Enzymatic action of prostate-specific antigen (PSA or hK3) : Substrate specificity and regulation by Zn2+, a tight-binding inhibitor
- Contribution to journal › Article
- 1999
-
Mark
The prognostic value of different forms of prostate specific antigen and their ratios in patients with prostate cancer
- Contribution to journal › Article
-
Mark
Characterization of epitope structure for 53 monoclonal antibodies against prostate-specific antigen
- Contribution to journal › Article
-
Mark
Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy
- Contribution to journal › Article
-
Mark
Reactivity of anti-PSA monoclonal antibodies with recombinant human kallikrein-2
- Contribution to journal › Article
-
Mark
Prostate-specific antigen and other serum markers : Current concepts from the world health organization second international consultation on prostate cancer
- Contribution to journal › Scientific review
- 1998
-
Mark
Metabolism of free and complexed prostate - specific antigen and their utility for diagnosis and prognosis of prostate cancer
(1998)
- Thesis › Doctoral thesis (compilation)
-
Mark
Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./Ml. Prostate specific antigen
- Contribution to journal › Article
